Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-032048
Filing Date
2022-11-14
Accepted
2022-11-14 16:16:20
Documents
33
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 319511
2 ex31-1.htm EX-31.1 20602
3 ex31-2.htm EX-31.2 20602
4 ex32-1.htm EX-32.1 9949
5 ex32-2.htm EX-32.2 9909
  Complete submission text file 0001493152-22-032048.txt   1437522

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gjcu-20220930.xsd EX-101.SCH 9804
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gjcu-20220930_cal.xml EX-101.CAL 18002
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gjcu-20220930_def.xml EX-101.DEF 11596
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gjcu-20220930_lab.xml EX-101.LAB 94190
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gjcu-20220930_pre.xml EX-101.PRE 68193
27 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 137856
Mailing Address 4125 BLACKHAWK PLAZA CIRCLE SUITE 166 DANVILLE CA 94506
Business Address 4125 BLACKHAWK PLAZA CIRCLE SUITE 166 DANVILLE CA 94506 (925)-362-3169
NP Life Sciences Health Industry Group Inc. (Filer) CIK: 0001781726 (see all company filings)

EIN.: 832912878 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56140 | Film No.: 221385590
SIC: 8200 Services-Educational Services